Barclays Downgrades Biogen (BIIB) to Underweight
Tweet Send to a Friend
Barclays downgrades Biogen (Nasdaq: BIIB) from Equal Weight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
